دورية أكاديمية
Novel Autologous Dendritic Cell Therapy AVT001 for Type 1 Diabetes.
| العنوان: | Novel Autologous Dendritic Cell Therapy AVT001 for Type 1 Diabetes. |
|---|---|
| المؤلفون: | Gaglia, Jason L, Daley, Heather L, Bryant, Nora K, Ritz, Jerome, Dong, Tuochuan, Skyler, Jay S, Jiang, Hong |
| المصدر: | NEJM Evid ; ISSN:2766-5526 ; Volume:3 ; Issue:7 |
| بيانات النشر: | Atypon |
| سنة النشر: | 2024 |
| المجموعة: | PubMed Central (PMC) |
| الوصف: | CD8+ T regulatory (Treg) cells that recognize the nonclassical class 1b molecule Qa-1/human leukocyte antigen E (Q/E CD8+ Treg cells) are important in maintaining self-tolerance. We sought to investigate the role that these T cells play in type 1 diabetes (T1D) pathogenesis and whether an intervention targeting this mechanism may delay T1D progression. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | https://doi.org/10.1056/EVIDoa2300238Test; https://pubmed.ncbi.nlm.nih.gov/38916421Test |
| DOI: | 10.1056/EVIDoa2300238 |
| الإتاحة: | https://doi.org/10.1056/EVIDoa2300238Test https://pubmed.ncbi.nlm.nih.gov/38916421Test |
| رقم الانضمام: | edsbas.814DF9EC |
| قاعدة البيانات: | BASE |
| DOI: | 10.1056/EVIDoa2300238 |
|---|